Maxwell Biosciences Awarded “Most Promising” 2022 Life Sciences Company in Texas Competition
Maxwell was presented with the award after pitching at the 10th annual Texas Life Science Forum hosted by BioHouston and the Rice Alliance for Technology and Entrepreneurship. The event engaged thought leadership with in the life science community with two days of panels, partnering, presentations and discussions.
Maxwell Biosciences was recognized alongside the 10 most promising life science companies selected by investors and presented by the Greater Houston Partnership.
49 companies — about half of them based in Houston — pitched their innovative solutions in therapeutics, drug development, medical devices, diagnostics and digital health. The presenting companies have already raised a combined total of more than $600 million in funding.
The day kicked off with a keynote from Dr. Stephen Hahn, CEO-partner of Flagship Pioneering and former Food and Drug Administration commissioner, along with remarks from leaders from the TMC, the University of Texas MD Anderson Cancer Center, TMC Innovation, Johnson & Johnson’s JLABS and Rice University.
“With attendance by over 600 individuals, including representatives from life science companies from California to Massachusetts — as well as internationally — this year’s event showcased the robust growth in our life science ecosystem since this event was first held a decade ago,” said Ann Tanabe, chief executive officer at BioHouston.
